Clinical trial
Expression of miR-155 in Migraine: Association With Different Phenotypes and Disease Severity
NCT05891808 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expression of miR-155 in Migraine: Association With Different Phenotypes and Disease Severity
- Lead sponsor
- IRCCS National Neurological Institute "C. Mondino" Foundation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 22, 2020
- Completion date
- January 1, 2024
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.